February 02, 2018
1 min read

Eyenovia completes $27.3 million initial public offering

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Eyenovia has closed its initial public offering of 2.73 million shares of its common stock, according to a press release.

Gross proceeds from the offering, before underwriting discounts and commissions, were $27.3 million. The company has granted underwriters a 30-day option to purchase up to 409,500 additional shares.

Eyenovia is developing ophthalmology products with its piezo-print technology to topically deliver microtherapeutics to the eye.

Ladenburg Thalmann & Co., a subsidiary of Ladenburg Thalmann Financial Services, and Roth Capital partners were joint book-running managers for the offering, the release said.